BNIP3P26

Across TCGA pan-cancer cohorts, BNIP3P26 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated BNIP3P26 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher BNIP3P26 RNA is associated with better overall survival. In most high-consensus cancer types, elevated BNIP3P26 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

LUAD, LAML, and ACC are the cancer types where BNIP3P26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.852	0.773	.003	46	view →
LAML	DFS	Tertile	All	0.633	0.332	.005	34	view →
ACC	DFS	Median	IV	0.570	0.087	.003	26	view →
THYM	DFS	Tertile	II,III,IV	0.933	0.595	.002	25	view →
LGG	OS	Tertile	All	0.384	0.559	<.001	25	view →
KICH	DFS	Median	III,IV	0.299	1.000	.004	18	view →
PRAD	OS	Tertile	All	0.843	0.938	.008	18	view →
KIRC	DFS	Quartile	All	0.706	0.472	.014	16	view →
BLCA	DFS	Quartile	All	0.133	0.426	.005	10	view →
LUSC	DFS	Tertile	All	0.272	0.458	.004	10	view →
SKCM	DFS	Tertile	IV	0.201	0.558	.025	9	view →
MESO	DFS	Quartile	III,IV	0.228	0.392	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

BNIP3P26–LUAD (OS)

Open the LUAD breakdown →